P

Inventor

WELCHER ANDREW A

US19 patents
⚠️ This page may combine multiple inventors who share the name “WELCHER ANDREW A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

AMGEN INC

16 patents
US5981245ANov 9, 1999

EPH-like receptor protein tyrosine kinases

AMGEN INC178 citations98
US5824303AOct 20, 1998

Eck receptor ligands

AMGEN INC61 citations95
US7335743B2Feb 26, 2008

Human anti-IFN-γ neutralizing antibodies as selective IFN-γ pathway inhibitors

AMGEN INC45 citations93
US7790859B2Sep 7, 2010

Human anti-IFN-γ neutralizing antibodies as selective IFN-γ pathway inhibitors

AMGEN INC24 citations92
US5981246ANov 9, 1999

Nucleic acids encoding EPH-like receptor protein tyrosine kinases

AMGEN INC21 citations92
US5650504AJul 22, 1997

Nucleic acids encoding eck receptor ligands

AMGEN INC24 citations92
US8906371B2Dec 9, 2014

Human anti-IFN-γ neutralizing antibodies as selective IFN-γ pathway inhibitors

AMGEN INC3 citations73
US5716934AFeb 10, 1998

Eck receptor ligands

AMGEN INC13 citations73
US7041796B2May 9, 2006

C3b/C4b Complement Receptor-like molecules and uses thereof

AMGEN INC7 citations72
US11230597B2Jan 25, 2022

Methods of treatment using an interferon gamma inhibitor

AMGEN INC4 citations64
US6992175B1Jan 31, 2006

Nucleic acids encoding Eph-like receptor tyrosine kinases

AMGEN INC4 citations62
US6656707B2Dec 2, 2003

C3b/C4b complement receptor-like molecules and uses thereof

AMGEN INC2 citations61
US6479250B1Nov 12, 2002

Eck receptor ligands

AMGEN INC2 citations61
US11156600B2Oct 26, 2021

Assay for detecting TH1 and TH2 cell populations

AMGEN INC0 citations53
US6087167AJul 11, 2000

Eck receptor ligands

AMGEN INC0 citations51
US10156562B2Dec 18, 2018

Assay for detecting Th1 and Th2 cell populations

AMGEN INC0 citations42

WELCHER ANDREW A

2 patents

UNIV YALE

1 patent